China, Hong Kong stocks set for capital rush with 6 Fed rate cuts incoming: Lombard Odier



Swiss private bank Lombard Odier expects the US to cut interest rates six times from September until the end of 2026, causing more capital to flow into emerging markets and benefiting Chinese stocks and bonds in coming years.

The US Federal Reserve will start lowering rates in September and reduce its key rate to 3 per cent from the current 4.5 per cent by the end of next year through a total of six cuts, said Homin Lee, a senior macro strategist with the firm, in a market outlook briefing on Thursday.

This would reduce returns on US$7 trillion worth of money-market funds that invest in deposits, leading to a shift towards equities and bonds for better returns, according to John Woods, Lombard Odier’s chief investment officer and head of investment solutions for Asia.

“US dollar-based investors do not like the outlook of the currency and will switch into other currencies,” he said. “The weaker dollar, in our view, is likely to promote capital flows into the emerging markets, with Thailand, Singapore and Hong Kong all benefiting.”

The outlook was positive for Chinese stocks listed in Hong Kong, mainland China and the US, said Jack Siu, the firm’s head of discretionary portfolio management in Asia.

“The sentiment towards ‘everything but China’ probably will dissipate a bit further from where we were a few years back,” Siu said. “We are seeing an inflow to emerging markets that will benefit China, directly and indirectly, in both equities and bonds.”

The recent rally in the mainland equities market is very much a “liquidity-driven story” rather than one driven by strong corporate earnings, Woods said.

  • Related Posts

    JD.com posts first quarterly loss in nearly four years as delivery battle takes toll

    Chinese e-commerce giant JD.com reported a 2.7 billion yuan (US$392 million) loss in the fourth quarter and a halving of annual profit amid an ongoing food delivery battle it ignited…

    Continue reading
    China and Hong Kong should relax biotech listing rules, venture capitalist says

    Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *